Xconomy | Boston - Business + Technology in the Exponential Economy

Boston News Xpress

Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M

Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for bowel disorders like for irritable bowel syndrome and chronic constipation said it may raise as much as $172.5 million from investors through the deal, according to a prospectus filed late today.

The proposed offering would be underwritten by JP Morgan Securities, Morgan Stanley, Credit Suisse, Bank of America/Merrill Lynch, and Wedbush... Read more »

Comments | Reprints | Share:

IT, Software, Web 2.0

Day Software, Web 2.0 Content Management Specialist, Moving U.S. Headquarters to Boston

Wade Roush 11/20/09

Wails of lamentation spread across the local tech community every time an entity like Zendesk or Greylock or Y Combinator departs Boston for parts west. But today we have a different tale to report. Day Software... Read more »

Comments (1) | Reprints | Share:

Biotech, Drugs, Multiple Sclerosis

Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder

Luke Timmerman 11/20/09

[Update: 1:55 pm Eastern, 11/20/09] After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged mismanagement, Cambridge, MA-based Biogen Idec now faces another sharp attack from a major shareholder.... Read more »

Comments | Reprints | Share:

IT, deals, VC

Mind, Body, & Cash: Lighter Living Raises $3M

Ryan McBride 11/20/09

Pilates is famous for shaping up peoples’ buttocks, tummies, and thighs. But what can the popularity of this fitness phenomenon and the market for health products do for investment portfolios? Cambridge, MA-based Lighter Living, which operates... Read more »

Comments | Reprints | Share:

deals, VC, mergers and acquisitions

Metcalfe Reflects on $2.7B 3Com Buyout, MyPunchbowl Parent Adds New Punch, $30M More for Fate Therapeutics, & More Boston Deals News

Ryan McBride 11/20/09

Dealmakers appear to be getting their business done before the week of Thanksgiving—because we’ve seen a decent stream of deal closings involving Boston-area life sciences and tech companies over the past week or so.

—Framingham, MA-based... Read more »

Comments | Reprints | Share:

National
wwwade, IT, mapping

Using Google’s Building Maker to Change the Face of Boston

Wade Roush 11/20/09

Comments (2) | Reprints | Share:

San Diego
Biofuels, startups, Collaborations

Big Energy Collaborations Seen to Jump-Start Emerging Biofuels Technologies

Bruce V. Bigelow 11/19/09

Comments (2) | Reprints | Share:

Biotech, Multiple Sclerosis, Drugs

Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore

Luke Timmerman 11/19/09

Comments (12) | Reprints | Share:

Life Sciences, Roundup, Drug Development

A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News

Wade Roush 11/19/09

Comments (1) | Reprints | Share:

Biotech, Kidney Disease, Drugs

Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says

Luke Timmerman 11/18/09

Comments | Reprints | Share:

Xconomist Forum - Insight & Opinion

Entrepreneurship, startups, Education

On Founding a Company Fresh Out of College

Kevin Vogelsang 11/18/09

On May 18th of 2009, I signed the papers to legally incorporate my first company. Three weeks later, I graduated from MIT with my BS in biological engineering. Fast forward, and after... Read more »

Comments (4) | Reprints | Share:

startups, deals, VC

Negotiating a Better Series A Deal

Sim Simeonov 11/12/09

[Updated 11/18/09, see below] This post is about how to get a better deal from VCs investing in your first round of financing. It is also about how to... Read more »

Comments (17) | Reprints | Share:

Seattle
Economy, Markets, IPOs

Cautious Perspectives on Recovery in the IPO, M&A, and Credit Markets

Taft Kortus 11/12/09

The second half of 2009 provided a good measure of optimism, easing some of the pain investors felt toward the end of 2008 and in early 2009. The stock market has... Read more »

Comments | Reprints | Share: